AFTINET and health organisations make submission to the IP Australia review of pharmaceutical patents

AFTINET, the Public Health Association and three other health organisations have made a submission to the review of pharmaceutical patents because the issue of patents and medicine is a key issue in the Trans-Pacific Partnership Agreement (TPPA) negotiations. The US is demanding much stronger patent laws which would allow pharmaceutical companies to charge high prices for medicines for longer periods. Our submission argues that there is no evidence for stronger patent laws, and that the Australian government should reject such requests in the TPPA. See the submission here.